Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
36
SRPT Quote, Financials, Valuation and Earnings
Last price:
$118.99
Seasonality move
:
12.18%
Day range:
$118.56 - $121.00
52-week range:
$91.34 - $173.25
Dividend yield:
0%
P/E ratio:
77.25x
P/S ratio:
7.30x
P/B ratio:
9.31x
Volume:
1.7M
Avg. volume:
1.1M
1-year change:
31.76%
Market cap:
$11.4B
Revenue:
$1.2B
EPS (TTM):
$1.54
SRPT Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for Sarepta Therapeutics shares anticipate an average target of $185.10, ranging from a low estimate of $75.00 to a high estimate of $219.00. This average target implies a growth of 55.59% compared to the current stock price of $118.97.
Consensus Price Target
$185.10
Highest Price Target
$219.00
Lowest Price Target
$75.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 12 | 12 | 12 |
| Hold | 3 | 0 | 0 |
| Sell | 0 | 1 | 1 |
| Consensus | Buy | Buy | Buy |
SRPT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
